Stockhub

IBEX Technologies Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 11:2911:29, 21 September 2022 95.149.241.133 talk 1,084 bytes +1,084 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, Germany, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue compon..."
Retrieved from "https://stockhub.co/research/IBEX_Technologies_Inc."